Skip to main content

Table 4 Interaction analysis between metabolic syndrome and SNAFLD status on mortality

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Subgroup

Case

Total number

HR (95% CI)

p value

MetS(−)SNAFLD(−)

62 (12.4)

500

1.000

MetS(+)SNAFLD(−)

49 (31.8)

154

1.845 (1.024–3.323)

0.012*

MetS(−)SNAFLD(+)

21 (30.9)

68

1.910 (1.254–2.908)

0.010*

MetS(+)SNAFLD(+)

23 (54.8)

42

4.958 (2.710–9.071)

0.004*

RERI

2.203 (0.197–4.210)

 

AP

0.444 (0.222–0.667)

SI

2.256 (1.252–4.065)

  1. SNAFLD, significant non-alcoholic fatty livers disease, MetS metabolic syndrome
  2. *represent the p value < 0.05. MetS metabolic syndrome, SNAFLD significant non-alcoholic fatty liver disease
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us